Osteogenic Growth Peptide (10-14) - CAS# 105250-85-9 246 is a dual antagonist of

is a dual antagonist of α4β7 and α4β1 integrins

9(12):e112925

CAS Number: 550-99-2

InChiKey: QQUHMASGPODSIW-ICECTASOSA-N

and efficacious S-nitrosoglutathione reductase (GSNOR) inhibitor and is currently undergoing clinical development for the treatment of acute asthma

Osteogenic Growth Peptide (10-14) - CAS# 105250-85-9 246 is a dual antagonist ofOsteogenic Growth Peptide (10 14) (OGP(10 14)), the C terminal truncated pentapeptide of osteogenic growth peptide (OGP), retains the full OGP like activity. Osteogenic Growth Peptide (10 14) is responsible for the binding to the OGP receptor and activates an intracellular Gi protein MAP kinase signaling pathway. Osteogenic Growth Peptide (10 14) is a potent mitogen and stimulator of osteogenesis and hematopoiesis. Osteogenic Growth Peptide (10 14)